Amphastar Pharmaceuticals/AMPH

$55.44

0.63%
-
1D1W1MYTD1YMAX

About Amphastar Pharmaceuticals

Amphastar Pharmaceuticals, Inc. is a bio-pharmaceutical company. The Company is focused on developing, manufacturing, marketing and selling generic and injectable, inhalation, and intranasal products, as well as insulin active pharmaceutical ingredient (API) products. It operates through two segments: finished pharmaceutical products and API products. The finished pharmaceutical products segment manufactures, markets and distributes Primatene MIST, epinephrine, glucagon, phytonadione, lidocaine, enoxaparin, naloxone, as well as various other critical and non-critical care drugs. The API segment manufactures and distributes RHI API and porcine insulin API for external customers and internal product development. Primatene Mist is an epinephrine inhalation product, which is indicated for the temporary relief of mild symptoms of intermittent asthma. Its portfolio also includes BAQSIMI (BAK-see-mee), which is used to treat very low blood sugar in people with diabetes ages 4 years and above.

Ticker

AMPH

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Jack Zhang

Employees

1,615

Headquarters

Rancho cucamonga, United States

AMPH Metrics

BasicAdvanced
$2.56B
Market cap
20.85
P/E ratio
$2.56
EPS
0.88
Beta
-
Dividend rate

What the Analysts think about AMPH

Analyst Ratings

Majority rating from 5 analysts.
Buy

Price Targets

Average projection from 4 analysts.
21.75% upside
High $71.00
Low $63.00
$55.44
Current price
$67.50
Average price target

AMPH Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
27.25% profit margin
QuarterlyAnnual
Q3 23
QoQ growth
Revenue
$180.5M
23.88%
Net income
$49.2M
88.51%
Profit margin
27.25%
52.15%

AMPH Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 65.53%
QuarterlyAnnual
Q4 22
Q1 23
Q2 23
Q3 23
Q4 23
Actual
$0.73
$0.62
$0.65
$1.15
-
Expected
$0.41
$0.48
$0.56
$0.69
$0.91
Surprise
79.71%
30.42%
16.02%
65.53%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

Buy or sell Amphastar Pharmaceuticals stock

Buy or sell Amphastar Pharmaceuticals stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing